Status:

COMPLETED

Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC

Lead Sponsor:

OHSU Knight Cancer Institute

Collaborating Sponsors:

National Cancer Institute (NCI)

Oregon Health and Science University

Conditions:

Colorectal Carcinoma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study collects information to provide a model for how to rapidly adapt and scale-up multilevel interventions through clinic-health plan partnerships to reduce the burden of colorectal cancer (CRC...

Detailed Description

PRIMARY OBJECTIVE: I. Adapt, pilot, then test the implementation and scale-up of targeted direct mail and patient navigation programs. OUTLINE: This is an implementation-effectiveness trial of dire...

Eligibility Criteria

Inclusion

  • CCOs/CCO STAFF: Serving a majority of counties that are predominantly rural based on 2010 Rural-Urban Commuting Area (RUCA) codes (codes 4-10)
  • CCOs/CCO STAFF: Willing to participate in data collection activities (e.g., producing claims data, interviews)
  • CLINICS: Clinics will be eligible for the cluster randomization if there are 30 or more patients eligible for screening
  • CLINICS: Are classified as rural according to RUCA (Codes 4-10) or Oregon Office of Rural Health designations
  • CLINICS: Are served by CCOs agreeing to participate in the project
  • CLINICS: Willing to implement the intervention into their clinic for the study
  • CLINIC STAFF/PROVIDERS: Employed as a clinician or ancillary staff member in a participating clinic
  • CLINIC STAFF/PROVIDERS: Willing to participate in data collection activities (e.g., interviews, observation, surveys)
  • PATIENTS: Attributed to participating clinic
  • PATIENTS: Are enrolled in Medicaid or dual eligible
  • PATIENTS: Eligible for colorectal cancer (CRC) screening
  • PATIENTS: For the subset of patients that will be invited to participate in key informant interviews, a 5th eligibility criteria is consented to participate
  • COMMUNITY OR REGIONAL/ORGANIZATIONAL PARTNERS: (Includes endoscopy providers, community-based outreach workers, or leaders from regional or national organizations who participate in the pilot, pragmatic trial, or scale-up study)
  • COMMUNITY OR REGIONAL/ORGANIZATIONAL PARTNERS: Involved in study activities (training, care delivery)
  • COMMUNITY OR REGIONAL/ORGANIZATIONAL PARTNERS: Willing to participate in data collection activities (e.g., trainings, interviews, surveys)
  • Elderly - Yes - we anticipate that a limited number of clinic and CCO staff, or community organization representatives may be elderly; we limit our patient recruitment to those aged 45-75
  • Rural - Yes
  • Inner city - No
  • Low income - Yes
  • Disabled - Yes
  • Chronic care - Yes
  • End of life - Yes - This is possible, but we predict limited numbers because of the types of individuals we are recruiting: clinic and CCO staff, and patients who are not currently in hospice care
  • Minorities - Yes

Exclusion

  • CLINICS: Clinics are excluded if they have current or ongoing participating in other mailed fecal testing research projects in the Medicaid population
  • PATIENTS: Are current for screening
  • PATIENTS: Comorbid conditions that make patients poor candidates for screening based on clinical judgment (e.g., end-stage renal disease, enrollment in hospice)
  • PATIENTS: Are not an established patient or for other reasons documented by the clinics
  • All patients that we recruit will be at least 45 years of age or older

Key Trial Info

Start Date :

May 14 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2024

Estimated Enrollment :

5696 Patients enrolled

Trial Details

Trial ID

NCT04890054

Start Date

May 14 2021

End Date

July 1 2024

Last Update

August 19 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

OHSU Knight Cancer Institute

Portland, Oregon, United States, 97239